Literature DB >> 24777827

Diagnostic potential of recombinant nonstructural protein 3B to detect antibodies induced by foot-and-mouth disease virus infection in bovines.

Amiya Kumar Mohapatra1, Jajati Keshari Mohapatra, Laxmi Kant Pandey, Aniket Sanyal, Bramhadev Pattnaik.   

Abstract

Detection of antibodies to nonstructural proteins (NSP) of foot-and-mouth disease virus is the preferred diagnostic method to differentiate infected from vaccinated animals. In India, an endemic region practising preventive biannual vaccination, 3AB3 indirect ELISA (r3AB3 I-ELISA) has been employed as the primary screening test for serosurveillance. However, because of the variability observed in the immune response to the NSPs, the likelihood of detecting or confirming an infected animal is increased if an antibody profile against multiple NSPs is considered for diagnosis. In this study, all three copies of NSP 3B were expressed in a prokaryotic system to develop an indirect ELISA (r3B I-ELISA). At the decided cutoff of 40 percent positivity, the diagnostic sensitivity and specificity of the r3B I-ELISA were estimated to be 92.1% (95% CI: 89.0-94.5) and 98.1% (95% CI: 96.9-98.8), respectively, as compared to 97.04% and 95.04% for r3AB3 I-ELISA. Although r3B I-ELISA displayed lower sensitivity compared to the screening assay, which could possibly be attributed to additional relevant B-cell epitopes in the carboxy-terminal half of the 3A protein, the former achieved considerably higher specificity on repeatedly vaccinated animals. NSP antibodies could be detected from 10 to as late as 998 days postinfection in experimental calves. Substantial agreement in the test results (90.6%) was found between the two ELISAs. The r3B I-ELISA, when used in conjunction with the r3AB3 I-ELISA as an integrated system, can potentially augment the efficiency and confidence of detection of infected herds against the backdrop of intensive vaccination.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24777827     DOI: 10.1007/s00705-014-2089-0

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  4 in total

Review 1.  Diagnostic assays developed for the control of foot-and-mouth disease in India.

Authors:  Gaurav Kumar Sharma; Sonalika Mahajan; Rakesh Matura; Saravanan Subramaniam; Rajeev Ranjan; Jitendra Biswal; Manoranjan Rout; Jajati Keshari Mohapatra; Bana Bihari Dash; Aniket Sanyal; Bramhadev Pattnaik
Journal:  World J Virol       Date:  2015-08-12

2.  Pan-Serotype Diagnostic for Foot-and-Mouth Disease Using the Consensus Antigen of Nonstructural Protein 3B.

Authors:  Alyssa K Van Dreumel; Wojtek P Michalski; Leanne M McNabb; Brian J Shiell; Nagendrakumar B Singanallur; Grantley R Peck
Journal:  J Clin Microbiol       Date:  2015-03-18       Impact factor: 5.948

3.  Chemiluminescence Immunoassay for the Detection of Antibodies against the 2C and 3ABC Nonstructural Proteins Induced by Infecting Pigs with Foot-and-Mouth Disease Virus.

Authors:  Zezhong Liu; Junjun Shao; Furong Zhao; Guangqing Zhou; Shandian Gao; Wei Liu; Jianliang Lv; Xiumei Li; Yangfan Li; Huiyun Chang; Yongguang Zhang
Journal:  Clin Vaccine Immunol       Date:  2017-08-04

4.  Development of a competitive chemiluminescence immunoassay using a monoclonal antibody recognizing 3B of foot-and-mouth disease virus for the rapid detection of antibodies induced by FMDV infection.

Authors:  Wei Liu; Guanglei Zhang; Sicheng Yang; Junhui Li; Zhan Gao; Sudan Ge; Huihui Yang; Junjun Shao; Huiyun Chang
Journal:  Virol J       Date:  2021-09-26       Impact factor: 4.099

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.